We are focused on improving the health of individuals with Cystic Fibrosis and related lung conditions through research in several complementary areas including:

a) Regenerative Medicine, led by Prof. Ludovic Vallier (Cambridge Stem Cell Institute; WT Sanger Institute) and Dr Emma Rawlins (WT Gurdon Institute). 

b) Novel anti-inflammatory therapies (at preclinical and clinical stages of evaluation) 

c) Remote monitoring, as lead site for the CF Trust-funded National SmartCare Study 

d) Our bacterial research on Pseudomonas (c/w Dr Martin Welch, Biochemistry Cambridge), S. aureus , M. abscessus. 

e) Whole exome sequencing study of non-CF bronchiectasis

f) Our Clinical trials team at Papworth Hospital.